The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
The emergence of new infections in India is a growing concern
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
A committee to be formed to suggest measures for ensuring the safety of healthcare professionals
Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC) is indicated to relieve redness of the eye due to minor eye irritations.
The robotic surgery program has continually pushed the boundaries of medical technology
Becomes the first rehab & recovery center in east India to earn NABH accreditation
Subscribe To Our Newsletter & Stay Updated